Key statistics
As of last trade Ionis Pharmaceuticals Inc (ISI:BRN) traded at 37.06, 0.00% above its 52-week low of 37.06, set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 37.06 |
---|---|
High | 37.06 |
Low | 37.06 |
Bid | 37.60 |
Offer | 37.75 |
Previous close | 37.06 |
Average volume | -- |
---|---|
Shares outstanding | 157.53m |
Free float | 156.30m |
P/E (TTM) | -- |
Market cap | 6.15bn USD |
EPS (TTM) | -2.53 USD |
Data delayed at least 15 minutes, as of Apr 18 2024.
More ▼
Press releases
- Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
- Ionis announces pricing of $500.3 million public offering
- Ionis announces proposed public offering of common stock
- Ionis to present at upcoming investor conferences
- Ionis reports second quarter 2024 financial results
- Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen
- Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome
- Ionis to hold second quarter 2024 financial results webcast
- Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease
- Alltrna Announces Updates to Its Board of Directors
More ▼